Alstonine as an antipsychotic: Effects on brain amines and metabolic changes

Evidence-based Complementary and Alternative Medicine

Volumn 2011, Issue , 2011, Pages

  Linck, Viviane M ^a   Herrmann, Ana P ^a   Piato, Ángelo L ^a   Detanico, Bernardo C ^a   Figueiró, Micheli ^a   Flório, Jorge ^b   Iwu, Maurice M ^c   Okunji, Christopher O ^c   Leal, Mirna B ^a   Elisabetsky, Elaine ^a  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c UNIVERSITY OF NIGERIA   (Nigeria)

Author keywords

[No Author keywords available]

Indexed keywords

ALSTONINE; BRAIN AMINE; CLOZAPINE; DIHYDROXYPHENYLACETIC ACID; DOPAMINE 2 RECEPTOR; GLUCOSE; HALOPERIDOL; NEUROLEPTIC AGENT; PROLACTIN; SEROTONIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CATABOLISM; CONTROLLED STUDY; CORPUS STRIATUM; DRUG EFFECT; DRUG STRUCTURE; FRONTAL CORTEX; GLUCOSE BLOOD LEVEL; HYPOGLYCEMIA; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; SEROTONIN BLOOD LEVEL; SEROTONINERGIC TRANSMISSION; WEIGHT GAIN;

EID: 80052691633     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1093/ecam/nep002     Document Type: Article

References (35)

1. Miyamoto S., Duncan G. E., Marx C. E., Lieberman J. A., Treatments for schizophrenia: a critical review of pharmacology and mechanisms of action of antipsychotic drugs Molecular Psychiatry 2005 10 1 79 104 (Pubitemid 40139590)
2. Compton M. T., Miller A. H., Antipsychotic-induced hyperprolactinemia and sexual dysfunction Psychopharmacology Bulletin 2002 36 1 143 164
3. Kane J., Honigfeld G., Singer J., Meltzer H., Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine Archives of General Psychiatry 1988 45 9 789 796
4. Lieberman J. A., Scott Stroup T., McEvoy J. P., Swartz M. S., Rosenheck R. A., Perkins D. O., Keefe R. S. E., Davis S. M., Davis C. E., Lebowitz B. D., Severe J., Hsiao J. K., Effectiveness of antipsychotic drugs in patients with chronic schizophrenia The New England Journal of Medicine 2005 353 12 1209 1223 (Pubitemid 41345943)
5. Allison D. B., Mentore J. L., Heo M., Chandler L. P., Cappelleri J. C., Infante M. C., Weiden P. J., Antipsychotic-induced weight gain: a comprehensive research synthesis American Journal of Psychiatry 1999 156 11 1686 1696 (Pubitemid 29517559)
6. Dwyer D. S., Model of the 3-D structure of the GLUT3 glucose transporter and molecular dynamics simulation of glucose transport Proteins 2001 42 4 531 541 (Pubitemid 32179862)
7. Dwyer D. S., Donohoe D., Induction of hyperglycemia in mice with atypical antipsychotic drugs that inhibit glucose uptake Pharmacology Biochemistry and Behavior 2003 75 2 255 260 (Pubitemid 36859808)
8. Schultz S. H., North S. W., Shields C. G., Schizophrenia: a review American Family Physician 2007 75 12 1821 1829 (Pubitemid 46954070)
9. Elias A. N., Hofflich H., Abnormalities in glucose metabolism in patients with schizophrenia treated with atypical antipsychotic medications American Journal of Medicine 2008 121 2 98 104 (Pubitemid 351199456)
10. Gardner D. M., Baldessarini R. J., Waraich P., Modern antipsychotic drugs: a critical overview Canadian Medical Association Journal 2005 172 13 1703 1711 (Pubitemid 40896865)
11. Alex K. D., Pehek E. A., Pharmacologic mechanisms of serotonergic regulation of dopamine neurotransmission Pharmacology and Therapeutics 2007 113 2 296 320 (Pubitemid 46149046)
12. Abi-Dargham A., Do we still believe in the dopamine hypothesis? New data bring new evidence International Journal of Neuropsychopharmacology 2004 7 supplement 1 S1 S5 (Pubitemid 38436990)
13. Costa-Campos L., Elisabetsky E., Lara D. R., Carlson T. J., King S. R., Ubillas R., Nunes D. S., Iwu M. M., Nkemjika C. O., Ozioko A., Agwu C. O., Antipsychotic profile of alstonine: ethnopharmacology of a traditional Nigerian botanical remedy Anais da Academia Brasileira de Cincias 1999 71 2 189 201
14. Costa-Campos L., Lara D. R., Nunes D. S., Elisabetsky E., Antipsychotic-like profile of alstonine Pharmacology Biochemistry and Behavior 1998 60 1 133 141 (Pubitemid 28236623)
15. Costa-Campos L., Dassoler S. C., Rigo A. P., Iwu M., Elisabetsky E., Anxiolytic properties of the antipsychotic alkaloid alstonine Pharmacology Biochemistry and Behavior 2004 77 3 481 489 (Pubitemid 38296807)
16. de Moura Linck V., Herrmann A. P., Goerck G. C., Iwu M. M., Okunji C. O., Leal M. B., Elisabetsky E., The putative antipsychotic alstonine reverses social interaction withdrawal in mice Progress in Neuropsychopharmacology and Biological Psychiatry 2008 32 6 1449 1452
17. Okunji C. O., Iwu M. M., Ito Y., Smith P. L., Preparative separation of indole alkaloids from the rind of Picralima nitida (Stapf) T. Durand H. Durand by pH-zone-refining countercurrent chromatography Journal of Liquid Chromatography and Related Technologies 2005 28 5 775 783 (Pubitemid 40316287)
18. Ito Y., Ito Y., Conway W. D., High-speed countercurrent chromatography High-Speed Countercurrent Chromatography Chemical Analysis 1996 New York, NY, USA Wiley-Interscience 225 263
19. Shinomiya K., Menet J. M., Fales H. M., Ito Y., Studies on a new cross-axis coil planet centrifuge for performing countercurrent chromatography. 1. Design of the apparatus, retention of the stationary-phase, and efficiency in the separation of proteins with polymer phase systems Journal of Chromatography 1993 644 215 229 (Pubitemid 23242453)
20. Felicio L. F., Florio J. C., Sider L. H., Cruz-Casallas P. E., Bridges R. S., Reproductive experience increases striatal and hypothalamic dopamine levels in pregnant rats Brain Research Bulletin 1996 40 4 253 256 (Pubitemid 26286225)
21. Doretto M. C., Oliveira-e-Silva M., Ferreira-Alves D. L., Pires S. G., Garcia-Cairasco N., Reis A. M., Effect of lactation on the expression of audiogenic seizures: association with plasma prolactin profiles Epilepsy Research 2003 54 2-3 109 121 (Pubitemid 36776729)
22. Costa-Campos L., Iwu M., Elisabetsky E., Lack of pro-convulsant activity of the antipsychotic alkaloid alstonine Journal of Ethnopharmacology 2004 93 307 310 (Pubitemid 38962421)
23. Westerink B. H. C., Sequence and significance of dopamine metabolism in the rat brain Neurochemistry International 1985 7 2 221 227 (Pubitemid 15116200)
24. Haleem D. J., Batool F., Khan N. H., Kamil N., Ali O., Saify Z. S., Haleem M. A., Differences in the effects of haloperidol and clozapine on brain serotonin and dopamine metabolism and on tests related to extrapyramidal functions in rats Medical Science Monitor 2002 8 9 BR354 BR361
25. Lucas G., Spampinato U., Role of striatal serotonin(2A) and serotonin(2C) receptor subtypes in the control of in vivo dopamine outflow in the rat striatum Journal of Neurochemistry 2000 74 2 693 701 (Pubitemid 30053742)
26. Di Matteo V., Cacchio M., Di Giulio C., Esposito E., Role of serotonin2C receptors in the control of brain dopaminergic function Pharmacology Biochemistry and Behavior 2002 71 4 727 734 (Pubitemid 34219223)
27. De Deurwaerdre P., Navailles S., Berg K. A., Clarke W. P., Spampinato U., Constitutive activity of the serotonin2C receptor inhibits in vivo dopamine release in the rat striatum and nucleus accumbens Journal of Neuroscience 2004 24 13 3235 3241 (Pubitemid 38451889)
28. Carlsson A., Waters N., Holm-Waters S., Tedroff J., Nilsson M., Carlsson M. L., Interactions between monoamines, glutamate, and GABA in schizophrenia: new evidence Annual Review of Pharmacology and Toxicology 2001 41 237 260 (Pubitemid 32385889)
29. Elisabetsky E., Costa-Campos L., The alkaloid alstonine: a review of its pharmacological properties Evidence-Based Complementary and Alternative Medicine 2006 3 1 39 48 (Pubitemid 43999650)
30. Arvanov V. L., Wang R. Y., A selective 5-HT2A receptor antagonist and a potential antipsychotic drug, facilitates N-methyl-d-aspartatereceptor mediated neurotransmission in the medial prefrontal cortical neurons in vitro Neuropsychopharmacology 1998 18 3 197 209 (Pubitemid 28062583)
31. Spurney C. F., Baca S. M., Murray A. M., Jaskiw G. E., Kleinman J. E., Hyde T. M., Differential effects of haloperidol and clozapine on ionotropic glutamate receptors in rats Synapse 1999 34 4 266 276 (Pubitemid 29523133)
32. Savoy Y. E., Ashton M. A., Miller M. W., Nedza F. M., Spracklin D. K., Hawthorn M. H., Rollema H., Matos F. F., Hajos-Korcsok E., Differential effects of various typical and atypical antipsychotics on plasma glucose and insulin levels in the mouse: Evidence for the involvement of sympathetic regulation Schizophrenia Bulletin 2010 36 2 410 418
33. Millan M. J., Loiseau F., Dekeyne A., Gobert A., Flik G., Cremers T. I., S33138 (N-[4-[2-[(3aS,9bR)-8-cyano-1,3a,4,9b-tetrahydro[1] benzopyrano[3,4-c] pyrrol-2(3H)-yl)-ethyl]phenyl-acetamide), a preferential dopamine D3 versus D2 receptor antagonist and potential antipsychotic agent: III. Actions in models of therapeutic activity and induction of side effects Journal of Pharmacology and Experimental Therapeutics 2008 324 1212 1226 (Pubitemid 351397860)
34. Rung J. P., Carlsson A., Markinhuhta K. R., Carlsson M. L., (+)-MK801 induced social withdrawal in rats; a model for negative symptoms of schizophrenia Progress in Neuro-Psychopharmacology Biological Psychiatry 2005 29 827 832 (Pubitemid 40897800)
35. Rourke C., Starr K. R., Reavill C., Fenwick S., Deadman K., Jones D. N. C., Effects of the atypical antipsychotics olanzapine and risperidone on plasma prolactin levels in male rats: a comparison with clinical data Psychopharmacology 2006 184 1 107 114 (Pubitemid 43005763)